Toscotec to supply two TADVISION machines to Hengan Group in China
Toscotec will supply two TADVISION® tissue machines to Hengan International Group at its Shandong and Hunan mills in China. Toscotec’s TADVISION® line is designed to ensure superior bulk, softness and absorbency. With this order, Hengan breaks through the barrier of conventional and textured tissue in the Chinese market, aiming to manufacture top quality structured tissue with the highest bulk, softness and absorbency properties. The start-up is scheduled for 2022.
The new lines will be the first real TAD (Through Air Drying) machines manufacturing structured tissue to be installed in China. The Fujian-based Chinese Group is thus set to lead the transformation of the Chinese tissue market towards top quality tissue.
Both TADVISION® machines will have a trim width of 3,650 mm and an annual production capacity of over 40,000 tons.
This project strengthens the cooperation between Toscotec and Hengan International Group, who in 2017 successfully fired up two Toscotec-supplied MODULO-PLUS ES tissue lines at its Changji mill in Xinjiang province.
Hui Lin Chit, CEO of Hengan Group, says, “Hengan always pursues innovation and top quality products; as a result, it leads the development of the Chinese tissue and hygiene market. After scrupulous evaluation, we selected Toscotec as the partner to support us to achieve our new target.”
Alessandro Mennucci, CEO of Toscotec, says, “We are very pleased to partner with Hengan on this strategic project. Toscotec’s new TADVISION® machine represents the cutting-edge technology they need to bring about a historical change in the Chinese market.”
Michael Zhao, General Manager of Toscotec Paper Machine (Shanghai) Co., Ltd., says, “The Chinese tissue market has been tackling the issue of overcapacity in recent years. Our latest TADVISION® machine will enable Hengan to manufacture a completely differentiated and top quality product. This will allow them to both set apart from the fierce red ocean competition of conventional tissue, and to open up and lead an entirely new, blue ocean structured tissue market.”
